M

Monogram Orthopaedics Inc
NASDAQ:MGRM

Watchlist Manager
Monogram Orthopaedics Inc
NASDAQ:MGRM
Watchlist
Price: 6 USD -1.8% Market Closed
Market Cap: 243.8m USD

Monogram Orthopaedics Inc
Net Change in Cash

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Monogram Orthopaedics Inc
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
M
Monogram Orthopaedics Inc
NASDAQ:MGRM
Net Change in Cash
$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cadre Holdings Inc
NYSE:CDRE
Net Change in Cash
$37.2m
CAGR 3-Years
6%
CAGR 5-Years
98%
CAGR 10-Years
N/A
Glaukos Corp
NYSE:GKOS
Net Change in Cash
-$2.8m
CAGR 3-Years
33%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Stryker Corp
NYSE:SYK
Net Change in Cash
-$594m
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
UFP Technologies Inc
NASDAQ:UFPT
Net Change in Cash
$1.9m
CAGR 3-Years
N/A
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Alphatec Holdings Inc
NASDAQ:ATEC
Net Change in Cash
$39.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Monogram Orthopaedics Inc
Glance View

Market Cap
243.8m USD
Industry
N/A

Monogram Orthopaedics Inc is a US-based company operating in industry. The company is headquartered in Brooklyn, New York. The company went IPO on 2023-05-18. Monogram Orthopaedics Inc. (Monogram) is engaged in developing a product solution architecture for mass personalization of orthopedic implants by linking three-dimensional (3D) printing and robotics via automated digital image analysis algorithms. Its primary business is to market orthopedic implants insertable with its orthopedic robot. The company has a navigated robot prototype that can optically track a simulated surgical target and execute optimized auto-generated cut paths for precision insertion of implants in synthetic bone specimens. These implants and cut paths are generated with Monogram software algorithms. The Monogram technology platform consists of a workflow to prepare a patient-specific surgical plan from a computed tomography scan. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.

MGRM Intrinsic Value
Not Available

See Also

What is Monogram Orthopaedics Inc's Net Change in Cash?
Net Change in Cash
2.1m USD

Based on the financial report for Dec 31, 2024, Monogram Orthopaedics Inc's Net Change in Cash amounts to 2.1m USD.

What is Monogram Orthopaedics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
-34%

Over the last year, the Net Change in Cash growth was -34%.

Back to Top